Anula Kusum Jayasuriya

Anula Kusum Jayasuriya

Directeur/Membre du Conseil chez JAGUAR HEALTH, INC.

Fortune : 13 304 $ au 31/05/2026

69 ans
Health Technology
Finance
Commercial Services

Profil

Anula Kusum Jayasuriya is the founder of Ocimum Bio Solutions (India) Ltd., founded in 2000, serving as Managing Director.
Dr. Jayasuriya is the founder of Evolvence India Life Sciences Fund, founded in 2006.
Dr. Jayasuriya is the founder of EXXclaim Capital, founded in 2013, serving as Managing Director.
Dr. Jayasuriya is the founder of Kidron Capital Assets LP, founded in 2022, serving as Co-founding and Managing Partner.
Current jobs include Independent Chairman at Aarvik Therapeutics, Inc.; Independent Director at Lineage Cell Therapeutics, Inc. since 2021; Director at Level Playing Field Corp.; Director-Outcomes Research at Syntex Laboratories, Inc.; Director at Ocimum Biosolutions, Inc.; Director at Gruter Institute for Law & Behavioral Research; Director at Mapmygenome India Ltd.; Independent Director at Jaguar Health, Inc. since 2022; Director at Solaria Bio, Inc.; Director at Watkins-Conti Products, Inc.; Trustee at Astia, Inc.; and Venture Partner at Digitaldx Ventures Management LLC since 2022.
Former jobs include Director at Lipomics Technologies, Inc.; Director at nVision Medical Corp.; Director at HealthCare Global Enterprises Ltd.; Director at Harvard Business School Health Industry Alumni Association; Director at LuMind Research Down Syndrome Foundation; Partner at TVM Capital GmbH; Partner at Skyline Management LLC; Partner at Skyline Ventures (California) from 2001 to 2002; Vice President-Corporate Development at Genomics Collaborative, Inc. from 1999 to 2000; Vice President-Global Drug Development at Hoffmann-La Roche, Inc. from 1994 to 1998; and Investment Advisor at RH Capital LLC.
Education includes undergraduate degree from Harvard University, graduate degree from the University of Cambridge, doctorate from Harvard Medical School, and MBAistration from Harvard Business School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/07/2026 10 000 ( 0% ) 13 300 $ 31/05/2026
15/04/2026 1 ( 0% ) 4 $ 31/05/2026

Postes actifs de Anula Kusum Jayasuriya

SociétésPosteDébut
LINEAGE CELL THERAPEUTICS, INC. Directeur/Membre du Conseil 04/05/2021
JAGUAR HEALTH, INC. Directeur/Membre du Conseil 01/07/2022
Private Equity Investor 01/07/2022
Directeur/Membre du Conseil -
Syntex Laboratories, Inc.
Corporate Officer/Principal -
Directeur Général 01/01/2013
Directeur/Membre du Conseil -
Président -
Directeur/Membre du Conseil -
░░░░░░ ░░░░░░░░░ ░░░ ░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -

Anciens postes connus de Anula Kusum Jayasuriya

SociétésPosteFin
░░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Anula Kusum Jayasuriya

Formation de Anula Kusum Jayasuriya

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

58

Relations au 1er degré

30

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées30

Health Technology

Health Technology

Health Services

Consumer Services

Finance

Health Technology

Finance

Consumer Services

Health Technology

Health Services

Syntex Laboratories, Inc.

Health Services

Commercial Services

Consumer Services

Commercial Services

Harvard Business School Health Industry Alumni Association

Commercial Services

Consumer Services

Finance

Health Services

Commercial Services

Health Technology

Finance

Finance

Health Technology

Miscellaneous

Commercial Services

Health Technology

Skyline Ventures (California)

  1. Bourse
  2. Insiders
  3. Anula Kusum Jayasuriya